BioSpace News Archive

Business

Cerus to Release Third Quarter 2018 Results on November 1, 2018

Cerus Corporation (Nasdaq:CERS) announced today that its third quarter results will be released on Thursday, November 1, 2018, after the close of the stock market.

October 23, 2018
·
1 min read
FDA

FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

OMS721 now with orphan designation covering both prevention and treatment of HSCT-TMA in U.S. and in Europe

October 23, 2018
·
7 min read
Biotech Beach

OSI Systems’ Optoelectronics and Manufacturing Division Receives $10 Million Order

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries.

October 23, 2018
·
2 min read
Genetown

XenoTherapeutics Executives Spearhead Initial Hurricane Michael Relief Efforts in Panama City, Florida

Company’s executives arrived on site within 48 hours after the storm hit to deliver medical and emergency supplies to Florida Panhandle residents

October 23, 2018
·
2 min read
Business

American Academy of Periodontology Honors Dr. Oded Bahat With Master Clinician Award

Periodontal expert honored by peers

October 23, 2018
·
1 min read
Business

Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company

Continues Development of Neuroscience Portfolio, Aiming to Bring New Therapies to Patients

October 23, 2018
·
8 min read
Pharm Country

Dr. Jill Biden, National Minority Quality Forum, Global Sponsors and CROs Discuss the Future of Healthcare and Clinical Research at Medidata NEXT NYC 2018

Over 1,000 industry leaders to discuss best practices and the hottest topics in the digital transformation of life sciences

October 23, 2018
·
2 min read
Drug Development

Cyxone Selects First Clinical Site Ahead of Phase 1 Study With T20K in MS

Cyxone AB (publ) announced today that the company has selected the clinical site that will carry out the drug candidate T20K’s first in man study.

October 23, 2018
·
3 min read
Drug Development

MC2 Therapeutics Announces Topline Results Showing a Favorable Safety Profile and Reduction in Corneal Staining for MC2-03 in Dry Eye Patients with Moderate to Severe Keratitis

Active MC2-03 eye drop treatment resulted in a strong clinical improvement in severe dry eye patients over control arms both on CFS response (p=0.0090) and mean change from Baseline to Month 6 (p=0.0496)

October 23, 2018
·
4 min read
Media Advisory - Launch of new resource to help family physicians support individuals with mental health and substance use problems

Today, the Mental Health Commission of Canada (MHCC) and the College of Family Physicians of Canada (CFPC) will officially launch the Best Advice guide: Recovery-Oriented Mental Health and Addiction Care in the Patient’s Medical Home at the Canadian Mental Health Association’s 3rd annual Mental Health for All (MH4A) Conference.

October 23, 2018
·
1 min read